Chemical disaggregation of alpha-synuclein fibrils as a therapy for synucleinopathies.
作者信息
Wu Shenjie, Hernandez Villegas Nancy C, Schekman Randy
机构信息
Department of Molecular and Cell Biology, University of California, Berkeley, CA 94720.
HHMI, University of California, Berkeley, CA 94720.
出版信息
Proc Natl Acad Sci U S A. 2023 Mar 14;120(11):e2300965120. doi: 10.1073/pnas.2300965120. Epub 2023 Mar 8.
Abstract
摘要
相似文献
1
Chemical disaggregation of alpha-synuclein fibrils as a therapy for synucleinopathies.α-突触核蛋白原纤维的化学解聚作为突触核蛋白病的一种治疗方法。
Proc Natl Acad Sci U S A. 2023 Mar 14;120(11):e2300965120. doi: 10.1073/pnas.2300965120. Epub 2023 Mar 8.
2
Structural heterogeneity of α-synuclein fibrils amplified from patient brain extracts.从患者脑组织提取物中放大的α-突触核蛋白纤维的结构异质性。
Nat Commun. 2019 Dec 4;10(1):5535. doi: 10.1038/s41467-019-13564-w.
3
Quaternary structure of patient-homogenate amplified α-synuclein fibrils modulates seeding of endogenous α-synuclein.患者匀浆扩增的α-突触核蛋白纤维的四聚体结构调节内源性α-突触核蛋白的种子形成。
Commun Biol. 2022 Sep 30;5(1):1040. doi: 10.1038/s42003-022-03948-y.
4
Alpha-synuclein is highly prone to distribution in the hippocampus and midbrain in tree shrews, and its fibrils seed Lewy body-like pathology in primary neurons.α-突触核蛋白在树鼩中极易分布于海马体和中脑，其原纤维在原代神经元中引发路易小体样病理学。
Exp Gerontol. 2019 Feb;116:37-45. doi: 10.1016/j.exger.2018.12.008. Epub 2018 Dec 13.
5
Structure, function and toxicity of alpha-synuclein: the Bermuda triangle in synucleinopathies.α-突触核蛋白的结构、功能与毒性：突触核蛋白病中的百慕大三角
J Neurochem. 2016 Oct;139 Suppl 1:240-255. doi: 10.1111/jnc.13249. Epub 2015 Sep 11.
6
Dual Effects: Intrastriatal Injection of α-syn N103/tau N368 Preformed Fibrils Promotes Endogenous α-synuclein Aggregates in the Proximal Colon.双重作用：纹状体内注射α-突触核蛋白 N103/tau N368 预形成纤维促进近端结肠内源性α-突触核蛋白聚集。
J Parkinsons Dis. 2022;12(7):2097-2116. doi: 10.3233/JPD-223294.
7
Seeding variability of different alpha synuclein strains in synucleinopathies.不同α-突触核蛋白菌株在突触核蛋白病中的播散变异性。
Ann Neurol. 2019 May;85(5):691-703. doi: 10.1002/ana.25446. Epub 2019 Mar 27.
8
Hsp110 mitigates α-synuclein pathology in vivo.Hsp110 减轻体内 α-突触核蛋白病变。
Proc Natl Acad Sci U S A. 2019 Nov 26;116(48):24310-24316. doi: 10.1073/pnas.1903268116. Epub 2019 Nov 4.
9
Consequences of variability in α-synuclein fibril structure on strain biology.α-突触核蛋白纤维结构变异性对菌株生物学的影响。
Acta Neuropathol. 2022 Mar;143(3):311-330. doi: 10.1007/s00401-022-02403-w. Epub 2022 Feb 4.
10
A glutaminyl cyclase-catalyzed α-synuclein modification identified in human synucleinopathies.在人类神经核蛋白病中鉴定出一种谷氨酰胺环化酶催化的α-突触核蛋白修饰。
Acta Neuropathol. 2021 Sep;142(3):399-421. doi: 10.1007/s00401-021-02349-5. Epub 2021 Jul 26.
引用本文的文献
1
Secondary Processes Dominate the Quiescent, Spontaneous Aggregation of α-Synuclein at Physiological pH with Sodium Salts.在生理 pH 值和钠盐条件下，α-突触核蛋白的静止、自发聚集主要由二级过程主导。
ACS Chem Neurosci. 2023 Sep 6;14(17):3125-3131. doi: 10.1021/acschemneuro.3c00282. Epub 2023 Aug 14.
本文引用的文献
1
Small molecules disaggregate alpha-synuclein and prevent seeding from patient brain-derived fibrils.小分子使α-突触核蛋白解聚并防止源自患者脑源性纤维的种子形成。
Proc Natl Acad Sci U S A. 2023 Feb 14;120(7):e2217835120. doi: 10.1073/pnas.2217835120. Epub 2023 Feb 9.
2
Conformational change of α-synuclein fibrils in cerebrospinal fluid from different clinical phases of Parkinson's disease.帕金森病不同临床阶段脑脊液中α-突触核蛋白原纤维的构象变化
Structure. 2023 Jan 5;31(1):78-87.e5. doi: 10.1016/j.str.2022.11.013. Epub 2022 Dec 12.
3
Structure-based discovery of small molecules that disaggregate Alzheimer's disease tissue derived tau fibrils in vitro.基于结构的小分子发现，可在体外使阿尔茨海默病组织来源的 tau 纤维解聚。
Nat Commun. 2022 Sep 16;13(1):5451. doi: 10.1038/s41467-022-32951-4.
4
Amelioration of pathologic α-synuclein-induced Parkinson's disease by irisin.鸢尾素改善病理 α-突触核蛋白诱导的帕金森病。
Proc Natl Acad Sci U S A. 2022 Sep 6;119(36):e2204835119. doi: 10.1073/pnas.2204835119. Epub 2022 Aug 31.
5
The Parkinson's disease protein alpha-synuclein is a modulator of processing bodies and mRNA stability.帕金森病蛋白α-突触核蛋白是处理体和 mRNA 稳定性的调节剂。
Cell. 2022 Jun 9;185(12):2035-2056.e33. doi: 10.1016/j.cell.2022.05.008.
6
Modeling the cellular fate of alpha-synuclein aggregates: A pathway to pathology.模拟α-突触核蛋白聚集的细胞命运：通向病理学的途径。
Curr Opin Neurobiol. 2022 Feb;72:171-177. doi: 10.1016/j.conb.2022.01.003. Epub 2022 Feb 4.
7
α-Synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson's disease.α-突触核蛋白反义寡核苷酸作为帕金森病的疾病修饰治疗。
JCI Insight. 2021 Mar 8;6(5):135633. doi: 10.1172/jci.insight.135633.
8
Disassembly of Tau fibrils by the human Hsp70 disaggregation machinery generates small seeding-competent species.人源 Hsp70 解聚机器使 Tau 纤维解聚生成具有成核能力的小片段。
J Biol Chem. 2020 Jul 10;295(28):9676-9690. doi: 10.1074/jbc.RA120.013478. Epub 2020 May 28.
9
Structures of α-synuclein filaments from multiple system atrophy.多系统萎缩中α-突触核蛋白丝的结构。
Nature. 2020 Sep;585(7825):464-469. doi: 10.1038/s41586-020-2317-6. Epub 2020 May 27.
10
New insights on the structure of alpha-synuclein fibrils using cryo-electron microscopy.利用冷冻电子显微镜观察α-突触核蛋白纤维的结构的新见解。
Curr Opin Neurobiol. 2020 Apr;61:89-95. doi: 10.1016/j.conb.2020.01.014. Epub 2020 Feb 26.
Zotero 插件